Find your next paid study

Urotronic Inc.NCT06312722

~$10 – $8,750

The FLOW Registry: Functional and Longitudinal Outcomes With Waterjet Ablation

The purpose of this study is to create a database and prospective registry for data collection on patients with benign prostatic hyperplasia undergoing Aquabla…

Benign Prostatic Hyperplasia (BPH)

University of ChicagoNCT07430423

~$10 – $750

Benign Prostatic Hyperplasia

A Prospective, Multicenter, Double Blind, Randomized, Clinical Study to Evaluate the Safety and Efficacy of The FloStent in Men Suffering From Benign Prostatic Hyperplasia Symptoms

The goal of this study is to determine the safety and effectiveness of the FloStent, a medical device used to treat men with symptoms of Benign Prostatic Hyper…

Rivermark MedicalNCT06849258

~$10 – $7,500

Enlarged Prostate (BPH)Benign Prostatic Hyperplasia

MOSES 2.0 vs Quanta Magneto 150 Holmium Laser for Holmium Laser Enucleation of the prostate-a Randomized Controlled Trial

The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasi…

Northwestern UniversityNCT07632742

Benign Prostatic HyperplasiaEnlarged Prostate With Lower Urinary Tract SymptomsEnlarged Prostate (BPH)

The Utility of Emsella for Reducing Transient Stress Urinary Incontinence (tSUI) Following Holmium Laser Enucleation of the Prostate (HoLEP)

This study aims to investigate the effectiveness of the Emsella chair treatments at different timepoints. Before and after the holmium laser enucleation of the…

Northwestern UniversityNCT07580404

Customized TULSA-PRO Ablation Registry

This patient registry will capture data from patients who have been or who are undergoing the transurethral ultrasound ablation (TULSA) procedure as part of th…

Prostate CancerProstate AdenocarcinomaBenign Prostatic Hyperplasia

Profound Medical Inc.NCT05001477

~$10 – $1,050

Phase 4

Effect of Tranexamic Acid on Intraoperative Blood Loss in Patients Undergoing Aquablation for Benign Prostatic Hyperplasia: a Randomized Controlled Trial

This study aims to find out if tranexamic acid (TXA), a medication, works to decrease blood loss during a specific surgery called Aquablation therapy, which is…

Benign Prostatic Hyperplasia

Kaiser PermanenteNCT06710327

~$10 – $7,500

In-Office Transperineal Laser Ablation (TPLA) as a Salvage Treatment for Obstructive Benign Prostatic Hyperplasia (BPH) After Minimally Invasive Surgical Therapies (MIST)

Benign prostatic hyperplasia (BPH) is a common condition affecting aging men, often leading to lower urinary tract symptoms (LUTS). While Minimally Invasive Su…

Benign Prostatic Hyperplasia (BPH)

The Cleveland ClinicNCT07016620

~$10 – $750

Lower Urinary Tract SymptomsBenign Prostatic Hyperplasia

PRescription Exercise for Older Men With Urinary Disease (PROUD) Pilot Study

This is a single-center pilot randomized controlled trial among 68 physically "inactive" older men with lower urinary tract symptoms (LUTS) attributed to benig…

University of California, San FranciscoNCT06225479

~$10 – $5,625

Phase 2

A Phase 2b Randomized, Single-Center, Double Blind, Placebo Controlled, 2-Arm Study to Investigate Orally Administered Combination Therapies (5-alpha Reductase Inhibitor + Raloxifene) Compared With Monotherapy (5-alpha Reductase Inhibitor + Placebo) in Adult Patients With Benign Prostatic Hyperplasia (BPH)

SRD5A2 is a critical enzyme for prostatic development and growth, and the SRD5A2 inhibitor, finasteride, is used to treat benign prostatic hyperplasia (BPH). S…

BPH (Benign Prostatic Hyperplasia)Lower Urinary Track Symptoms

Beth Israel Deaconess Medical CenterNCT06944145

Phase 2

A Pilot Proof of Concept Single-arm Study Using PuraStat Following the Aquablation Procedure to Assess Reduction of Hematuria to Allow for Same Day Discharge

This is a pilot proof of concept single-arm study using PuraStat following Aquablation procedure to assess reduction of hematuria to allow for same day dischar…

HematuriaBenign Prostatic HyperplasiaLower Urinary Tract Symptoms

NYU Langone HealthNCT06948331

~$10 – $7,500

Benign Prostatic HyperplasiaProstate HyperplasiaProstate Disease+5 more

5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy

The study is being conducted to learn why some patients with Benign Prostatic Hyperplasia (BPH) do not respond to a commonly used treatment drug, Finasteride. …